A DDI Study to Investigate PK and Safety of Cefiderocol in Combination With Xeruborbactam in Healthy Adult Participants

NCT06547554 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Bacterial Infections

Interventions

DRUG: Xeruborbactam
DRUG: Cefiderocol
DRUG: Xeruborbactam/Cefiderocol
DRUG: Dextrose 5% in water

Sponsor

Qpex Biopharma, Inc.

Collaborators

[object Object]
[object Object]